David M. Holtzman, M.D., is the Andrew B. and Gretchen P. Jones Professor and chairman of the Department of Neurology at Washington University School of Medicine in St. Louis. He is also the associate director of the university’s Alzheimer's Disease Research Center and co-director of the program on protein aggregation and neurodegeneration for the Hope Center for Neurological Disorders. Dr. Holtzman has conducted groundbreaking studies on Alzheimer's disease and hypoxic-ischemic brain injury. His discoveries concerning the production of amyloid-beta at neuronal synapses and the identification of new ways to measure how amyloid-beta is produced and cleared from the human brain were named two of the top 50 scientific innovations in 2006 by Scientific American. His many honors include the American Academy of Neurology’s 2003 Potamkin Prize for Research on Alzheimer’s, Pick’s and Related Diseases, and a 2004 MERIT Award from the National Institute on Aging. In 2008, Dr. Holtzman was elected to the Institute of Medicine of the National Academy of Sciences. In addition to serving on numerous advisory committees, editorial boards and professional societies, Dr. Holtzman maintains an active role as a teacher and mentor of neurology residents as well as postdoctoral, graduate and medical students.
Last Modified September 17, 2012